Labcorp price target raised to $290 from $275 at Jefferies

Jefferies raised the firm’s price target on Labcorp (LH) to $290 from $275 and keeps a Buy rating on the shares. Q4 revenues and EPS were above expectations, while FY25 guide was above on the top-line and EPS bracketed expectations, notes the analyst. The firm views the stock as attractive with the diagnostics business providing insulation from “broader healthcare noise,” the analyst added.